Advertisement

Molecular Medicine

, Volume 21, Issue 1, pp 553–562 | Cite as

Administration of α-Galactosylceramide Improves Adenine-Induced Renal Injury

  • Cristhiane Favero Aguiar
  • Cristiane Naffah-de-Souza
  • Angela Castoldi
  • Matheus Corrêa-Costa
  • Tárcio T. Braga
  • Érika L. Naka
  • Mariane T. Amano
  • Débora T. R. S. Abate
  • Meire I. Hiyane
  • Marcos A. Cenedeze
  • Alvaro Pacheco e Silva Filho
  • Niels O. S. Câmara
Research Article

Abstract

Natural killer T (NKT) cells are a subset of lymphocytes that reacts to glycolipids presented by CD1d. Invariant NKT cells (iNKT) correspond to >90% of the total population of NKTs and reacts to a-galactosylceramide (αGalCer). αGalCer promotes a complex mixture of Th1 and Th2 cytokines, as interferon (IFN)-γ and interleukin (IL)-4. NKT cells and IFN-γ are known to participate in some models of renal diseases, but further studies are still necessary to elucidate their mechanisms. The aim of our study was to analyze the participation of iNKT cells in an experimental model of tubule-interstitial nephritis. We used 8-wk-old C57BL/6j, Jα18KO and IFN-γKO mice. They were fed a 0.25% adenine diet for 10 d. Both adenine-fed wild-type (WT) and Jα18KO mice exhibited renal dysfunction, but adenine-fed Jα18KO mice presented higher expression of kidney injury molecule-1 (KIM-1), tumor necrosis factor (TNF)-α and type I collagen. To analyze the role of activated iNKT cells in our model, we administered αGalCer in WT mice during adenine ingestion. After αGalCer injection, we observed a significant reduction in serum creatinine, proinflammatory cytokines and renal fibrosis. However, this improvement in renal function was not observed in IFN-γKO mice after αGalCer treatment and adenine feeding, illustrating that this cytokine plays a role in our model. Our findings may suggest that IFN-γ production is one of the factors contributing to improved renal function after αGalCer administration

Notes

Acknowledgments

The authors thank Masaru Taniguchi at the RIKEN Research Center for Allergy and Immunology (Japan) for Jα18KO mice and Paulo Albe for preparing the histology slides. This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP grant numbers 07/07139-3, 2012/02270-2 and 2012/16794-3) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Complex Fluids INCT). The funders had no role in study design, data collection and analysis; decision to publish; or preparation of the manuscript.

Supplementary material

10020_2015_2101553_MOESM1_ESM.pdf (3.4 mb)
Supplementary material, approximately 3523 KB.

References

  1. 1.
    Stevens LA, Coresh J, Greene T, Levey AS. (2006) Assessing kidney function: measured and estimated glomerular filtration rate. N. Engl. J. Med. 354:2473–83.CrossRefGoogle Scholar
  2. 2.
    Stockelman MG, et al. (1998) Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency. Am. J. Physiol. 275:F154–63.PubMedGoogle Scholar
  3. 3.
    Thadhani R, Pascual M, Bonventre JV. (1996) Acute renal failure. N. Engl. J. Med. 334:1448–60.CrossRefGoogle Scholar
  4. 4.
    Iwano M, et al. (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110:341–50.CrossRefGoogle Scholar
  5. 5.
    Liu Y. (2010) New insights into epithelial-mesenchymal transition in kidney fibrosis. J. Am. Soc. Nephrol. 21:212–22.CrossRefGoogle Scholar
  6. 6.
    Yokozawa T, Oura H, Koizumi F. (1985) 2,8-Dihydroxyadenine urolithiasis induced by dietary adenine in rats. Nihon Jinzo Gakkai shi. 27:371–8.PubMedGoogle Scholar
  7. 7.
    Engle SJ, et al. (1996) Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis. Proc. Nalt. Acad. Sci. U. S. A. 93:5307–12.CrossRefGoogle Scholar
  8. 8.
    Correa-Costa M, et al. (2011) Pivotal role of Tolllike receptors 2 and 4, its adaptor molecule MyD88, and inflammasome complex in experimental tubule-interstitial nephritis. PLoS One. 6:e29004.CrossRefGoogle Scholar
  9. 9.
    Okabe C, et al. (2013) NF-kappaB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy. Am. J. Physiol. Renal Physiol. 305:F155–63.CrossRefGoogle Scholar
  10. 10.
    Kronenberg M. (2005) Toward an understanding of NKT cell biology: progress and paradoxes. Ann. Rev. Immunol. 23:877–900.CrossRefGoogle Scholar
  11. 11.
    Chiu YH, et al. (1999) Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189:103–110.CrossRefGoogle Scholar
  12. 12.
    Arrenberg P, Halder R, Kumar V. (2009) Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens. J. Cell. Physiol. 218:246–50.CrossRefGoogle Scholar
  13. 13.
    Bendelac A, Savage PB, Teyton L. (2007) The biology of NKT cells. Ann. Rev. Immunol. 25:297–336.CrossRefGoogle Scholar
  14. 14.
    Van Kaer L. (2005) Alpha-galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 5:31–42.CrossRefGoogle Scholar
  15. 15.
    Yoshimoto T, Paul WE. (1994) CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285–95.CrossRefGoogle Scholar
  16. 16.
    Baccala R, Kono DH, Theofilopoulos AN. (2005) Interferons as pathogenic effectors in autoimmunity. Immunol. Rev. 204:9–26.CrossRefGoogle Scholar
  17. 17.
    Cui J, et al. (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1623–6.CrossRefGoogle Scholar
  18. 18.
    Kjeldsen L, Cowland JB, Borregaard N. (2000) Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim. Biophys. Acta. 1482:272–83.CrossRefGoogle Scholar
  19. 19.
    Hraba-Renevey S, Turler H, Kress M, Salomon C, Weil R. (1989) SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene. 4:601–8.PubMedGoogle Scholar
  20. 20.
    Mishra J, et al. (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 14:2534–43.CrossRefGoogle Scholar
  21. 21.
    Mishra J, et al. (2004) Neutrophil gelatinase-associated lipocalin: a novel early urinary bio-marker for cisplatin nephrotoxicity. Am. J. Nephrol. 24:307–15.CrossRefGoogle Scholar
  22. 22.
    Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. (2002) Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62:237–44.CrossRefGoogle Scholar
  23. 23.
    Ramesh G, Reeves WB. (2005) p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am. J. Physiol. Renal Physiol. 289:F166–74.CrossRefGoogle Scholar
  24. 24.
    Zeisberg M, Strutz F, Muller GA. (2001) Renal fibrosis: an update. Curr. Opin. Nephrol. Hypertens. 10:315–20.CrossRefGoogle Scholar
  25. 25.
    Strutz F, Zeisberg M. (2006) Renal fibroblasts and myofibroblasts in chronic kidney disease. J. Am. Soc. Nephrol. 17:2992–8.CrossRefGoogle Scholar
  26. 26.
    Eddy AA, Neilson EG. (2006) Chronic kidney disease progression. J. Am. Soc. Nephrol. 17:2964–6.CrossRefGoogle Scholar
  27. 27.
    Kadler KE, Holmes DF, Trotter JA, Chapman JA. (1996) Collagen fibril formation. Biochem. J. 316:1–11.CrossRefGoogle Scholar
  28. 28.
    Gurujeyalakshmi G, Giri SN. (1995) Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp. Lung Res. 21:791–808.CrossRefGoogle Scholar
  29. 29.
    Hyde DM, Henderson TS, Giri SN, Tyler NK, Stovall MY. (1988) Effect of murine gamma interferon on the cellular responses to bleomycin in mice. Exp. Lung Res. 14:687–704.CrossRefGoogle Scholar
  30. 30.
    Roark JH, et al. (1998) CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160:3121–7.PubMedGoogle Scholar
  31. 31.
    Brossay L, et al. (1997) Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 159:1216–24.PubMedGoogle Scholar
  32. 32.
    Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat. Rev. Nephrol. 6:643–56.CrossRefGoogle Scholar
  33. 33.
    Park O, et al. (2009) Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology. 49:1683–94.CrossRefGoogle Scholar
  34. 34.
    Kimura T, et al. (2004) Treatment with alphagalactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis. J. Immunol. 172:5782–9.CrossRefGoogle Scholar
  35. 35.
    Pereira RL, et al. (2012) Invariant natural killer T cell agonist modulates experimental focal and segmental glomerulosclerosis. PLoS One. 7:e32454.CrossRefGoogle Scholar
  36. 36.
    Mesnard L, et al. (2009) Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis. J. Am. Soc. Nephrol. 20:1282–92.CrossRefGoogle Scholar
  37. 37.
    Frucht DM, et al. (2001) IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 22:556–60.CrossRefGoogle Scholar
  38. 38.
    Flaishon L, et al. (2000) Autocrine secretion of interferon gamma negatively regulates homing of immature B cells. J. Exp. Med. 192:1381–8.CrossRefGoogle Scholar
  39. 39.
    Harris DP, et al. (2000) Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1:475–82.CrossRefGoogle Scholar
  40. 40.
    Baker J, Verneris MR, Ito M, Shizuru JA, Negrin RS. (2001) Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood. 97:2923–31.CrossRefGoogle Scholar
  41. 41.
    Asai O, et al. (1998) Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J. Clin. Invest. 101:1835–42.CrossRefGoogle Scholar
  42. 42.
    Knothe S, et al. (2011) The NKT cell ligand alphagalactosylceramide suppresses allergic airway inflammation by induction of a Th1 response. Vaccine. 29:4249–55.CrossRefGoogle Scholar
  43. 43.
    Abbas AK, Murphy KM, Sher A. (1996) Functional diversity of helper T lymphocytes. Nature. 383:787–93.CrossRefGoogle Scholar
  44. 44.
    Kimura A, et al. (2012) Interferon-gamma is protective in cisplatin-induced renal injury by enhancing autophagic flux. Kidney Int. 2:1093–104.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2015

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (https://doi.org/creativecommons.org/licenses/by-nc-nd/4.0/)

Authors and Affiliations

  • Cristhiane Favero Aguiar
    • 1
    • 2
  • Cristiane Naffah-de-Souza
    • 2
  • Angela Castoldi
    • 2
  • Matheus Corrêa-Costa
    • 2
  • Tárcio T. Braga
    • 2
  • Érika L. Naka
    • 1
  • Mariane T. Amano
    • 2
  • Débora T. R. S. Abate
    • 2
  • Meire I. Hiyane
    • 2
  • Marcos A. Cenedeze
    • 1
  • Alvaro Pacheco e Silva Filho
    • 1
    • 3
  • Niels O. S. Câmara
    • 1
    • 2
  1. 1.Laboratory of Clinical and Experimental Immunology, Nephrology DivisionFederal University of São PauloSão PauloBrazil
  2. 2.Laboratory of Transplantation Immunobiology, Department of Immunology, Institute of Biomedical Sciences IVUniversity of São PauloSão PauloBrazil
  3. 3.Instituto Israelita de Ensino e Pesquisa Albert Einstein, Renal Transplantation UnitAlbert Einstein HospitalSão PauloBrazil

Personalised recommendations